NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002175

Registered date:10/07/2009

Comparison of the clinical responses by the dosage of once or triple a week of MTX in patients with rheumatoid Arthritis

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedRheumatoid Arthritis
Date of first enrollment2009/06/01
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)MTX, once a week MTX, triple a week

Outcome(s)

Primary OutcomeDAS28(CRP)
Secondary OutcomeEULAR Criteria Patient's Judgement

Key inclusion & exclusion criteria

Age minimum16years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriaDisqualified in patients with rheumatoid arthritis who judged by a doctor

Related Information

Contact

public contact
Name Motoriro Oribe
Address 1-8-15, Higasioomichi, Oita-city, Oita, Japan Japan
Telephone 097-513-7123
E-mail oribe-riuma@iris.ocn.ne.jp
Affiliation Oribe Rheumatism Clinic Rheumatology
scientific contact
Name Motoriro Oribe
Address 1-8-15, Higasioomichi, Oita-city, Oita, Japan Japan
Telephone 097-513-7123
E-mail
Affiliation Oribe Rheumatism Clinic Rheumatology